NCT06493578 — Non-segmental Vitiligo trial site landscape

Public-registry site landscape for NCT06493578, a Non-segmental Vitiligo study sponsored by Vyne Therapeutics Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT06493578 (registry record)
Sponsor	Vyne Therapeutics Inc.
Condition(s)	Non-segmental Vitiligo
Phase	PHASE2
Listed sites	49
Site countries	United States, Canada

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT06493578 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.